Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse

被引:0
|
作者
Paul Shapshak
Charurut Somboonwit
Lydia N. Drumright
Simon D.W. Frost
Deborah Commins
Timothy L. Tellinghuisen
William K. Scott
Robert Duncan
Clyde McCoy
J. Bryan Page
Brian Giunta
Francisco Fernandez
Elyse Singer
Andrew Levine
Alireza Minagar
Oluwadayo Oluwadara
Taiwo Kotila
Francesco Chiappelli
John T. Sinnott
机构
[1] University of South Florida Health,Division of Infectious Disease and International Medicine, Department of Internal Medicine
[2] College of Medicine,Department of Psychiatry and Behavioral Medicine
[3] University of South Florida,Hillsborough Health Department
[4] College of Medicine,Division of International Health, Department of Medicine
[5] Clinical Research Unit,Department of Veterinary Medicine
[6] University of California,Department of Pathology
[7] University of Cambridge,Miami Institute for Human Genomics
[8] University of Southern California Keck School of Medicine,Department of Epidemiology, Comprehensive Drug Research Center
[9] Scripps Research Institute,Department of Anthropology, University of Miami, Coral Gables, and Department of Psychiatry and Behavioral Sciences, Comprehensive Drug Research Center
[10] University of Miami Miller School of Medicine,Department of Neurology and National Neurological AIDS Bank
[11] University of Miami Miller School of Medicine,Department of Neurology
[12] University of Miami Miller School of Medicine,Division of Oral Biology and Medicine
[13] UCLA School of Medicine,Department of Anatomy, College of Medicine
[14] Louisiana State University Health Sciences Center,Department of Hematology
[15] UCLA School of Dentistry,undefined
[16] University of Ibadan,undefined
[17] College of Medicine and University College Hospital,undefined
[18] University of Ibadan,undefined
来源
关键词
Treg Cell; Injection Drug Abuse;
D O I
暂无
中图分类号
学科分类号
摘要
The spread of hepatitis C virus (HCV) infection involves a complex interplay of social risks, and molecular factors of both virus and host. Injection drug abuse is the most powerful risk factor for HCV infection, followed by sexual transmission and additional non-injection drug abuse factors such as co-infection with other viruses and barriers to treatment. It is clearly important to understand the wider context in which the factors related to HCV infection occur. This understanding is required for a comprehensive approach leading to the successful prevention, diagnosis, and treatment of HCV. An additional consideration is that current treatments and advanced molecular methods are generally unavailable to socially disadvantaged patients. Thus, the recognition of behavioral/social, viral, and host factors as components of an integrated approach to HCV is important to help this vulnerable group. Equally important, this approach is key to the development of personalized patient treatment — a significant goal in global healthcare.
引用
收藏
页码:153 / 179
页数:26
相关论文
共 50 条
  • [41] MOLECULAR CLASSIFICATION OF HEPATITIS-C VIRUS
    MIZOKAMI, M
    OHBA, K
    GASTROENTEROLOGIA JAPONICA, 1993, 28 : 42 - 44
  • [42] Advanced Molecular Surveillance of Hepatitis C Virus
    Goncalves Rossi, Livia Maria
    Escobar-Gutierrez, Alejandro
    Rahal, Paula
    VIRUSES-BASEL, 2015, 7 (03): : 1153 - 1188
  • [43] Hepatitis C virus molecular epidemiology in Uzbekistan
    Kurbanov, F
    Tanaka, Y
    Sugauchi, F
    Kato, H
    Ruzibakiev, R
    Zalyalieva, M
    Yunusova, Z
    Mizokami, M
    JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (03) : 367 - 375
  • [44] HEPATITIS-C VIRUS MARKERS FOR MONITORING INTERFERON THERAPY IN CHRONIC HEPATITIS-C
    SARACCO, G
    BALDI, M
    CALVO, PL
    MANZINI, P
    ABATE, M
    CHIABERGE, E
    BRUNETTO, MR
    RIZZETTO, M
    CHIEN, D
    KUO, G
    HOUGHTON, M
    BONINO, F
    HEPATOLOGY, 1991, 14 (04) : A75 - A75
  • [45] Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan
    Husseini, Abbas Ali
    Saeed, Khwaja Mir Islam
    Yurdcu, Esra
    Bozdayi, A. Mithat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31 (09): : 658 - 666
  • [46] DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS
    SODEYAMA, T
    KIYOSAWA, K
    URUSHIHARA, A
    MATSUMOTO, A
    TANAKA, E
    FURUTA, S
    AKAHANE, Y
    ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) : 1565 - 1572
  • [47] Molecular, genetic, and morphological markers during persistence of RNA-containing hepatitis C virus in the body
    Tolokonskaya, NP
    Nepomnyashchikh, GI
    Konenkov, VI
    Netesov, SV
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2001, 131 (02) : 145 - 149
  • [48] Molecular, Genetic, and Morphological Markers during Persistence of RNA-Containing Hepatitis C Virus in the Body
    N. P. Tolokonskaya
    G. I. Nepomnyashchikh
    V. I. Konenkov
    S. V. Netesov
    Bulletin of Experimental Biology and Medicine, 2001, 131 : 145 - 149
  • [49] Prevalence of hepatitis C virus genotypes in Spanish drug addicts with chronic hepatitis C
    Bravo, R
    Soriano, V
    GarciaSamaniego, J
    Gonzalez, J
    Castro, A
    Colmenero, M
    Carballo, E
    Mas, A
    GonzalezLahoz, J
    REVISTA CLINICA ESPANOLA, 1996, 196 (10): : 673 - 677
  • [50] 3-drug synergistic interactions of small molecular inhibitors of hepatitis C virus replication
    Grunberger, Christian
    Wyles, David L.
    Kaihara, Kelly A.
    Schooley, Robert T.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (01): : 42 - U1